Quick Takeaways
- Julie Garlikov has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $54,300.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Julie Garlikov
- Location
- Denver, CO
- Summary
- The estimated net worth of Julie Garlikov is at least $54,300 dollars as of 30 May 2024. Julie Garlikov is the Director of NovaBay Pharmaceuticals, Inc. and owns shares of NovaBay Pharmaceuticals, Inc. (NBY) stock worth about $54.3K.
- Signature
- /s/ Justin Hall as attorney in fact for Julie Garlikov
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Julie Garlikov and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: NovaBay Pharmaceuticals, Inc. ($54,300).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Julie Garlikov
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NBY | NovaBay Pharmaceuticals, Inc. | Director | $54,300 | 28 May 2024 |
Insider Transactions Reported by Julie Garlikov:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.